Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Aspire Pharma Strengthens European Footprint with Caragen Acquisition
Thursday, February 12, 2026Aspire Pharma Limited one of the UKs fastestgrowing specialty generics pharmaceutical businesses has acquired Caragen a Dublin based pharmaceutical organisation with a strong presence in hospital immunology therapies
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
Thursday, February 12, 2026Evogene Ltd a pioneering computational chemistry company specializing in the generative design of small molecules for the pharmaceutical and agricultural industries Systasy Bioscience GmbH a biotechnology company
Sanofi completes the acquisition of Dynavax
Wednesday, February 11, 2026Sanofi today announced that it has completed theacquisition of Dynavax Technologies Corporation Dynavax The acquisition includes Dynavaxs adult hepatitis B vaccine HEPLISAVB which is currently marketed in the US
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
Tuesday, February 10, 2026Memo Therapeutics AG MTx a latestage biotech company translating unique immune responses into superior medicines to treat viral infections and cancer today announced it has entered into a strategic collaboration and exclusive
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC
Tuesday, February 10, 2026Bruker Corporation today announced the launch of iNTApharma a labelfree characterization platform that provides singleparticle sensitivity for the quantitative analysis of nanoscale bioparticles in native aqueous media
17th Edition Strategic Alliance Management for Pharma
Tuesday, February 10, 2026The pharmaceutical industry is a highly regulated and researchintensive sector dedicated to discovering developing manufacturing and marketing drugs that improve human and animal health
Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
Friday, February 06, 2026Providence Therapeutics a Canadian clinicalstage mRNA biotechnology company is supporting a worldfirst clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and treatmentresistant brain tumors
Invivoscribe® Launches LeukoStrat® KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide
Thursday, February 05, 2026Invivoscribe a leader in precision medicine and measurable residual disease MRD testing today announced the addition of the LeukoStrat KMTA MRD Assay and Software to its industryleading oncology portfolio
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics
Wednesday, February 04, 2026Cycle Group Holdings Limited Cycle is delighted to announce it has completed the acquisition of NASDAQlisted Applied Therapeutics Inc NASDAQ APLT Applied a clinicalstage biopharmaceutical company
Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development
Tuesday, February 03, 2026Frontage Laboratories Inc Frontage a global Contract Research Development and Manufacturing Organization CRDMO today announced the expansion of its early phase clinical research capabilities across the United States and China
